RNA-seq re-validation confirmed that ZBTB7B knockdown resulted in reduced expression levels of LDHA and PD-L1 in tumor cells (Fig. 5B), establishing LDHA and PD-L1 as downstream effectors of ZBTB7B. The gene discussed is ZBTB7B; the disease is neoplasm.